Efficacy of metformin or Metact in type 2 Japnese patients with diabetes

Efficacy of metformin or Metact in type 2 Japnese patients with diabetes - Meatact study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009651

Enrollment

Registered

2013-01-01

Start date

2012-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

1000mg metformin MetactLD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Japanese patinets with type 2 diabetes who are in inadequate blood glucose control with 500mg metformin

Exclusion criteria

Exclusion criteria: allergy for metformin or pioglitazone renal failure type1 diabetes

Design outcomes

Primary

Measure	Time frame
Cervical IMT, HbA1c, serum adiponectin, serum osteopontin, PWV(pulse wave velocity)	—

Secondary

Measure	Time frame
body weight	—

Countries

Japan

Contacts

Public ContactTakashi Nomiyama

Fukuoka university, school of medicine Department of Endocrinology and Diabetes Mellitus

tnomiyama@fukuoka-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026